MedPath
NMPA Approval

Agalsidase Beta for Injection

国药准字SJ20190040

July 4, 2024

S20190040

Drug Information

注射用阿加糖酶β

法布赞

注射剂

5mg/瓶

生物制品

July 4, 2024

April 24, 2029

Company Information

Applicant Company

Sanofi B.V.

Paasheuvelweg 25,1105 BP Amsterdam, The Netherlands

Manufacturing Company

IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.